nafronyl has been researched along with Brain Diseases in 2 studies
Nafronyl: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.
Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lardot, C | 1 |
| Goemaere-Vanneste, J | 1 |
| van den Bosch de Aguilar, P | 1 |
| Foit, A | 1 |
| Bischoff, W | 1 |
| Breinlinger, U | 1 |
| Kornhuber, HH | 1 |
2 other studies available for nafronyl and Brain Diseases
| Article | Year |
|---|---|
[Action of naftidrofuryl in cerebral neovascularization after cortical lesion in rats].
Topics: Animals; Basement Membrane; Brain; Brain Diseases; Cell Division; Cerebral Cortex; Endothelium, Vasc | 1994 |
Effects of naftidrofuryl on pathological EEG topography.
Topics: Adult; Aged; Atrophy; Brain Diseases; Cerebral Cortex; Double-Blind Method; Electroencephalography; | 1988 |